# Molecular Imaging of Fibroblast Activation Protein Expression Using Labeled Technetium-99m HYNIC-FAPI

> **NCT07457541** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Tomsk National Research Medical Center of the Russian Academy of Sciences** · enrollment: 15 (estimated)

## Conditions studied

- Lung Cancer (Locally Advanced or Metastatic)
- Pancreas Cancer, Metastatic
- Breast Cancer (Locally Advanced or Metastatic)
- Colorectal Cancer (Locally Advanced or Metastatic)

## Interventions

- **DRUG:** [99mTc]Tc-HYNIC-FAPI

## Key facts

- **NCT ID:** NCT07457541
- **Lead sponsor:** Tomsk National Research Medical Center of the Russian Academy of Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-02-26
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-05-31
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2026-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07457541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07457541, "Molecular Imaging of Fibroblast Activation Protein Expression Using Labeled Technetium-99m HYNIC-FAPI". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07457541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*